Free tool
Healthcare stocks
We cover 1,613 companies in the Healthcare sector. The median market value in the group is $479.91M, measured across the 1,000 largest of them. Among those 1,000, the median move over the past trading day is −0.23%. 50% of the 969 with a 200-day average trade above it. Price change over the past year runs from −44.0% to +108.1% across the middle 80 percent of the group, with a median of +4.3%. Among those 1,000, 2 companies currently carry a tier A volume signal.
Other lists in this group
Table
1,613 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| ABTT34.SA | Abbott Laboratories | 49.40 BRL | +7.95% | −11.54% | −16.35% |
| ABT | Abbott Laboratories | $114.10 | +6.37% | −7.08% | −11.83% |
| GILD | Gilead Sciences, Inc. | $148.09 | +10.25% | +22.48% | +32.51% |
| GIS.DE | Gilead Sciences, Inc. | 126.78 EUR | +7.51% | +23.41% | +33.64% |
| PFE | Pfizer Inc. | $28.30 | +12.08% | +16.16% | +18.72% |
| PFE.DE | Pfizer Inc. | 24.44 EUR | +10.09% | +18.44% | +22.96% |
| DHER34.SA | Danaher Corporation | 39.85 BRL | +9.12% | −10.44% | +0.89% |
| DAP.DE | Danaher Corporation | 184.45 EUR | +4.06% | −5.68% | +6.90% |
| DHR | Danaher Corporation | $215.36 | +8.19% | −6.33% | +5.61% |
| VX1.DE | Vertex Pharmaceuticals Incorporated | 475.00 EUR | +10.21% | +23.55% | +41.64% |
| VRTX | Vertex Pharmaceuticals Incorporated | $547.29 | +11.60% | +21.05% | +40.66% |
| BMY | Bristol-Myers Squibb Company | $67.57 | +6.24% | +27.70% | +47.01% |
| BRM.DE | Bristol-Myers Squibb Company | 58.02 EUR | +3.74% | +28.56% | +50.84% |
| ISRG | Intuitive Surgical, Inc. | $370.42 | +2.38% | −34.09% | −21.38% |
| I1SR34.SA | Intuitive Surgical, Inc. | 95.28 BRL | +2.14% | −37.90% | −25.36% |
| IUI1.DE | Intuitive Surgical, Inc. | 318.75 EUR | +1.95% | −33.01% | −21.06% |
| SYK.DE | Stryker Corporation | 282.40 EUR | −8.40% | −4.46% | +34.90% |
| S1YK34.SA | Stryker Corporation | 84.97 BRL | −3.57% | −13.76% | −19.51% |
| SYK | Stryker Corporation | $329.67 | −4.88% | −5.06% | −15.52% |
| MDT | Medtronic plc | $92.02 | +5.92% | −3.41% | +2.29% |
| 2M6.DE | Medtronic plc | 78.54 EUR | +1.19% | −2.78% | +2.65% |
| SNW.DE | Sanofi | 78.75 EUR | −1.46% | +0.80% | −2.82% |
| SAN.PA | Sanofi | 78.74 EUR | −1.48% | +1.00% | −2.60% |
| SNY | Sanofi | $45.42 | −0.26% | −0.60% | −4.33% |
| G1SK34.SA | GSK plc | 53.80 BRL | +4.47% | +1.87% | +27.31% |
| MCK | McKesson Corporation | $896.65 | +0.80% | +8.98% | +31.57% |
| GSK | GSK plc | $51.43 | −4.25% | +5.41% | +32.23% |
| GSK.L | GSK plc | 1,905.50 GBP | −5.06% | +4.06% | +30.59% |
| GS71.DE | GSK plc | 22.35 EUR | −4.49% | +7.86% | +34.79% |
| HCA | HCA Healthcare, Inc. | $427.16 | +2.14% | −9.06% | +5.96% |
| A58.DE | Elevance Health, Inc. | 342.50 EUR | +2.03% | +13.81% | −19.30% |
| ELV | Elevance Health, Inc. | $402.54 | +4.36% | +14.33% | +32.12% |
| E1LV34.SA | Elevance Health, Inc. | 410.80 BRL | +3.62% | +6.85% | +21.66% |
| ESL.DE | EssilorLuxottica Société anonyme | 160.00 EUR | −2.85% | −38.15% | −39.11% |
| EL.PA | EssilorLuxottica Société anonyme | 159.15 EUR | −3.60% | −38.64% | −38.15% |
| REGN34.SA | Regeneron Pharmaceuticals, Inc. | 70.98 BRL | +20.22% | +2.34% | +33.80% |
| REGN | Regeneron Pharmaceuticals, Inc. | $814.79 | +17.21% | +5.24% | +39.36% |
| CGN.DE | The Cigna Group | 237.40 EUR | −9.42% | +0.45% | −8.78% |
| CI | The Cigna Group | $280.87 | −6.71% | +1.18% | −4.84% |
| 4519.T | Chugai Pharmaceutical Co., Ltd. | 6,953.00 JPY | −1.64% | −18.35% | +9.21% |
| MRK.DE | Merck KGaA | 139.35 EUR | −3.96% | +17.18% | +32.17% |
| BSX | Boston Scientific Corporation | $48.17 | +4.58% | −49.14% | −54.50% |
| BSX.DE | Boston Scientific Corporation | 42.30 EUR | +3.18% | −47.52% | −53.11% |
| M1RN34.SA | Moderna, Inc. | 38.45 BRL | +173.08% | +353.42% | +462.13% |
| COR | Cencora, Inc. | $327.79 | +2.57% | −2.88% | +13.45% |
| MRNA | Moderna, Inc. | $149.66 | +168.18% | +384.96% | +496.25% |
| TAK | Takeda Pharmaceutical Company Limited | $18.23 | +4.05% | +16.71% | +22.68% |
| 4502.T | Takeda Pharmaceutical Company Limited | 5,791.00 JPY | −0.96% | +19.85% | +36.03% |
| BAYN.DE | Bayer Aktiengesellschaft | 49.26 EUR | +3.29% | +30.00% | +76.91% |
| BAY.WA | Bayer Aktiengesellschaft | 210.50 PLN | +2.53% | +34.11% | +76.59% |
| C1AH34.SA | Cardinal Health, Inc. | 1,234.64 BRL | +2.68% | +6.79% | +52.41% |
| CAH | Cardinal Health, Inc. | $238.40 | +2.53% | +16.17% | +61.05% |
| 207940.KS | Samsung Biologics Co.,Ltd. | 1,589,000.00 KRW | +7.44% | −5.59% | +2.12% |
| EWL.DE | Edwards Lifesciences Corporation | 77.24 EUR | +2.88% | +7.49% | +11.65% |
| EW | Edwards Lifesciences Corporation | $90.78 | +8.48% | +6.39% | +12.21% |
| 7741.T | HOYA Corporation | 24,525.00 JPY | +3.20% | +2.32% | +28.99% |
| SHL.DE | Siemens Healthineers AG | 39.70 EUR | +5.75% | −7.90% | −14.18% |
| E1WL34.SA | Edwards Lifesciences Corporation | 105.71 BRL | 0.00% | −8.81% | −4.72% |
| HUM | Humana Inc. | $391.06 | +0.60% | +48.61% | +33.14% |
| H1UM34.SA | Humana Inc. | 44.52 BRL | +0.95% | +39.09% | +24.36% |
| MDLN | Medline Inc. | $35.64 | −12.02% | −12.26% | −13.07% |
| RVMD | Revolution Medicines, Inc. | $215.44 | +17.18% | +172.64% | +466.35% |
| H6D0.DE | Haleon plc | 4.34 EUR | −3.02% | +2.63% | +5.39% |
| HLN | Haleon plc | $10.17 | −0.97% | +3.05% | +6.13% |
| HLN.L | Haleon plc | 369.60 GBP | −2.66% | −0.12% | +2.68% |
| I1DX34.SA | IDEXX Laboratories, Inc. | 572.47 BRL | −0.27% | −24.21% | −17.31% |
| TEVA | Teva Pharmaceutical Industries Limited | $37.92 | +19.73% | +22.52% | +110.08% |
| IX1.DE | IDEXX Laboratories, Inc. | 468.10 EUR | −2.09% | −17.59% | +17.97% |
| A | Agilent Technologies, Inc. | $155.08 | +10.35% | +12.88% | +31.46% |
| IDXX | IDEXX Laboratories, Inc. | $553.44 | −2.83% | −17.40% | −13.64% |
| ONC | BeOne Medicines AG | $375.80 | +13.72% | +20.83% | +25.21% |
| WAT | Waters Corporation | $414.17 | +7.88% | +8.43% | +40.57% |
| 4578.T | Otsuka Holdings Co., Ltd. | 12,260.00 JPY | +6.56% | +35.48% | +57.62% |
| VEE.DE | Veeva Systems Inc. | 211.20 EUR | +15.44% | +12.55% | +13.43% |
| VEEV | Veeva Systems Inc. | $244.91 | +21.72% | +11.58% | −16.58% |
| RPRX | Royalty Pharma plc | $61.80 | +3.05% | +60.57% | +74.00% |
| 2U3.DE | Alcon Inc. | 62.62 EUR | +2.25% | −4.76% | −7.70% |
| ALC | Alcon Inc. | $72.67 | +5.15% | −5.89% | −10.24% |
| RMD | ResMed Inc. | $235.69 | +12.79% | −3.22% | −15.77% |
| RMD.AX | ResMed Inc. | 32.47 AUD | +8.27% | −9.89% | −24.75% |
| D1EX34.SA | DexCom, Inc. | 9.21 BRL | +28.45% | +22.96% | +9.64% |
| DXCM | DexCom, Inc. | $88.96 | +18.85% | +33.69% | +16.47% |
| DC4.DE | DexCom, Inc. | 77.60 EUR | +16.52% | +37.44% | +21.06% |
| GEHC | GE HealthCare Technologies Inc. | $73.31 | +14.35% | −11.40% | −1.15% |
| 4568.T | Daiichi Sankyo Company, Limited | 2,874.50 JPY | −0.42% | −17.47% | −17.94% |
| BIIB | Biogen Inc. | $221.07 | +7.52% | +24.32% | +62.12% |
| C1NC34.SA | Centene Corporation | 340.30 BRL | −2.49% | +53.30% | +116.61% |
| IDP.DE | Biogen Inc. | 190.12 EUR | +0.21% | +26.49% | +65.32% |
| CNC | Centene Corporation | $65.47 | +2.44% | +56.70% | +127.01% |
| DUL.DE | Alnylam Pharmaceuticals, Inc. | 204.00 EUR | −19.59% | −40.19% | −10.21% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $239.00 | −17.13% | −40.28% | −47.38% |
| ZOE.DE | Zoetis Inc. | 65.74 EUR | −4.92% | −38.01% | −49.47% |
| ZTS | Zoetis Inc. | $77.52 | +0.01% | −37.91% | −49.50% |
| Z1TS34.SA | Zoetis Inc. | 24.94 BRL | +0.56% | −40.91% | −52.31% |
| 068270.KS | Celltrion, Inc. | 190,900.00 KRW | +6.06% | −5.73% | +11.19% |
| A1LN34.SA | Alnylam Pharmaceuticals, Inc. | 62.25 BRL | −15.31% | −44.14% | −49.35% |
| FRE.DE | Fresenius SE & Co. KGaA | 45.85 EUR | +2.98% | −1.28% | +1.64% |
| BNTX | BioNTech SE | $112.56 | +21.75% | +16.41% | +9.27% |
| MTD | Mettler-Toledo International Inc. | $1,398.46 | +0.73% | −0.92% | +8.81% |
| MTO.DE | Mettler-Toledo International Inc. | 1,222.00 EUR | +4.27% | +2.22% | +13.15% |
| INSM | Insmed Incorporated | $124.39 | +19.46% | −29.77% | −7.54% |
| 4503.T | Astellas Pharma Inc. | 2,392.50 JPY | +4.23% | +14.03% | +53.57% |
| ROIV | Roivant Sciences Ltd. | $36.75 | +8.60% | +67.58% | +206.51% |
| PHG | Koninklijke Philips N.V. | $26.99 | +5.64% | +3.59% | +1.27% |
| PHI1.DE | Koninklijke Philips N.V. | 23.42 EUR | +2.76% | +5.23% | +3.22% |
| INCY | Incyte Corporation | $128.12 | −1.39% | +26.33% | +51.01% |
| WST | West Pharmaceutical Services, Inc. | $349.92 | +3.90% | +26.81% | +42.61% |
| 4543.T | Terumo Corporation | 2,557.50 JPY | +7.35% | +13.84% | −2.68% |
| STE | STERIS plc | $236.77 | +2.79% | −5.07% | −4.41% |
| GH | Guardant Health, Inc. | $170.92 | +19.01% | +68.00% | +169.17% |
| THC | Tenet Healthcare Corporation | $274.19 | +4.40% | +37.47% | +50.70% |
| DIM.PA | Sartorius Stedim Biotech S.A. | 194.30 EUR | +13.49% | −6.30% | +11.64% |
| 56S1.DE | Sartorius Stedim Biotech S.A. | 194.20 EUR | +13.30% | −7.09% | +11.32% |
| GMAB | Genmab A/S | $33.75 | +16.38% | +6.07% | +36.20% |
| SRT3.DE | Sartorius Aktiengesellschaft | 246.50 EUR | +9.26% | −0.18% | +25.88% |
| VIA.DE | Viatris Inc. | 14.27 EUR | −9.28% | +38.01% | +67.32% |
| VTRS | Viatris Inc. | $16.85 | −5.66% | +37.39% | +66.19% |
| ZBH | Zimmer Biomet Holdings, Inc. | $101.38 | +5.88% | +12.93% | −4.32% |
| MEDP | Medpace Holdings, Inc. | $619.05 | +8.42% | +8.41% | +30.74% |
| SOBI.ST | Swedish Orphan Biovitrum AB (publ) | 469.60 SEK | −0.76% | +42.13% | +61.26% |
| JAZZ | Jazz Pharmaceuticals plc | $249.29 | −2.97% | +43.97% | +100.35% |
| ASND | Ascendis Pharma A/S | $250.25 | −1.65% | +17.33% | +29.66% |
| IPN.PA | Ipsen S.A. | 166.00 EUR | +1.41% | +42.98% | +40.80% |
| COLO-B.CO | Coloplast A/S | 462.50 DKK | +6.22% | −12.68% | −20.60% |
| CBHD.DE | Coloplast A/S | 61.54 EUR | +5.85% | −5.48% | +7.91% |
| NBIX | Neurocrine Biosciences, Inc. | $156.59 | −14.35% | +11.37% | +13.36% |
| SOLV | Solventum Corporation | $91.53 | +6.22% | +15.83% | +25.57% |
| SRT.DE | Sartorius Aktiengesellschaft | 195.00 EUR | +9.92% | +0.74% | +21.79% |
| BBIO | BridgeBio Pharma, Inc. | $79.37 | −7.22% | +1.45% | +60.05% |
| 4507.T | Shionogi & Co., Ltd. | 2,892.00 JPY | −5.80% | +2.05% | +15.63% |
| FPH.AX | Fisher & Paykel Healthcare Corporation Limited | 36.47 AUD | +5.19% | +12.67% | +11.27% |
| RDOR3.SA | Rede D'Or São Luiz S.A. | 35.30 BRL | +2.86% | −12.41% | +1.37% |
| ESF0.DE | Eurofins Scientific SE | 72.70 EUR | +7.58% | +17.51% | +12.65% |
| 7733.T | Olympus Corporation | 2,162.50 JPY | +16.11% | +8.42% | +27.06% |
| COO | The Cooper Companies, Inc. | $72.68 | +0.86% | −10.39% | −1.93% |
| EXEL | Exelixis, Inc. | $56.10 | −0.73% | +28.73% | +45.68% |
| RVTY | Revvity, Inc. | $126.35 | +13.31% | +28.91% | +42.93% |
| BAX | Baxter International Inc. | $26.50 | +8.74% | +35.96% | +8.90% |
| PME.AX | Pro Medicus Limited | 181.86 AUD | +10.93% | −18.09% | −39.15% |
| B1AX34.SA | Baxter International Inc. | 67.70 BRL | +8.81% | +27.70% | +3.61% |
| ORNBV.HE | Orion Oyj | 80.80 EUR | −1.76% | +29.38% | +21.01% |
| ORNAV.HE | Orion Oyj | 80.50 EUR | −1.83% | +29.71% | +21.27% |
| ICLR | ICON Public Limited Company | $168.93 | −6.27% | −10.46% | −2.91% |
| CORT | Corcept Therapeutics Incorporated | $119.80 | +27.19% | +213.61% | +71.81% |
| PEN | Penumbra, Inc. | $323.05 | +0.96% | +4.41% | +21.02% |
| BMRN | BioMarin Pharmaceutical Inc. | $65.61 | +5.70% | +10.36% | +11.85% |
| FME.DE | Fresenius Medical Care AG | 40.36 EUR | −7.39% | +4.49% | −2.61% |
| REC.MI | Recordati Industria Chimica e Farmaceutica S.p.A. | 52.70 EUR | +2.53% | +10.68% | +1.80% |
| ELAN | Elanco Animal Health Incorporated | $25.08 | −1.72% | +11.37% | +35.64% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $89.12 | +3.89% | +31.46% | +308.99% |
| FMS | Fresenius Medical Care AG | $23.40 | −5.45% | +3.54% | −3.21% |
| R1VT34.SA | Revvity, Inc. | 20.60 BRL | +3.00% | +10.27% | +22.81% |
| MDGL | Madrigal Pharmaceuticals, Inc. | $538.88 | +0.01% | −9.26% | +26.78% |
| TEM | Tempus AI, Inc. | $68.48 | +59.63% | +9.81% | −6.49% |
| SNN | Smith & Nephew plc | $29.30 | −10.01% | −9.54% | −19.49% |
| SN.L | Smith & Nephew plc | 1,068.00 GBP | −12.06% | −12.27% | −22.42% |
| EHC | Encompass Health Corporation | $120.78 | +4.09% | +13.77% | −1.75% |
| DVAI34.SA | DaVita Inc. | 938.25 BRL | −23.86% | +44.22% | +18.80% |
| A1LG34.SA | Align Technology, Inc. | 208.52 BRL | −5.78% | −2.37% | +7.83% |
| DVA | DaVita Inc. | $180.05 | −24.81% | +57.24% | +30.89% |
| SMMT | Summit Therapeutics Inc. | $14.23 | +13.39% | −18.78% | −42.63% |
| TECH | Bio-Techne Corporation | $72.38 | +0.43% | +21.73% | +29.33% |
| BTSG | BrightSpring Health Services, Inc. | $61.35 | −15.33% | +59.77% | +156.37% |
| ALGN | Align Technology, Inc. | $159.14 | −9.37% | +1.99% | +12.09% |
| AFW.DE | Align Technology, Inc. | 143.00 EUR | −6.14% | +7.68% | −54.37% |
| GMED | Globus Medical, Inc. | $83.10 | +3.13% | −4.81% | +35.10% |
| CYTK | Cytokinetics, Incorporated | $79.20 | −0.31% | +28.30% | +109.36% |
| AXSM | Axsome Therapeutics, Inc. | $207.15 | −11.55% | +15.93% | +69.99% |
| I1QV34.SA | IQVIA Holdings Inc. | 84.64 BRL | −67.80% | −72.39% | −67.19% |
| GKOS | Glaukos Corporation | $180.57 | +19.32% | +63.09% | +89.83% |
| KRYS | Krystal Biotech, Inc. | $359.76 | −1.23% | +45.70% | +143.67% |
| MOH | Molina Healthcare, Inc. | $199.63 | −0.35% | +11.86% | +13.35% |
| IONS | Ionis Pharmaceuticals, Inc. | $63.36 | +14.58% | −20.47% | +48.21% |
| PRAX | Praxis Precision Medicines, Inc. | $377.37 | +27.57% | +31.76% | +704.28% |
| UHS | Universal Health Services, Inc. | $178.69 | +7.50% | −18.65% | −1.76% |
| KYMR | Kymera Therapeutics, Inc. | $125.55 | +18.26% | +72.55% | +197.09% |
| ENSG | The Ensign Group, Inc. | $180.63 | −1.37% | +3.89% | +5.01% |
| HSIC | Henry Schein, Inc. | $90.38 | +5.45% | +17.65% | +31.02% |
| BIM.PA | bioMérieux S.A. | 75.50 EUR | +3.64% | −31.05% | −35.91% |
| ABVX.PA | ABIVAX Société Anonyme | 102.30 EUR | −5.63% | −11.04% | +48.91% |
| RDY | Dr. Reddy's Laboratories Limited | $12.22 | +4.18% | −11.83% | −14.19% |
| ABVX | ABIVAX Société Anonyme | $116.52 | −6.21% | −12.90% | +46.70% |
| RHCPA.AX | Ramsay Health Care Limited | 108.65 AUD | +0.60% | +1.45% | +1.45% |
| GHRS | GH Research PLC | $29.01 | +3.76% | +119.11% | +112.84% |
| VIMIAN.ST | Vimian Group AB (publ) | 35.35 SEK | +1.58% | +15.22% | +12.01% |
| PIII | P3 Health Partners Inc. | $9.92 | −5.70% | +183.43% | +26.37% |
| PGNY | Progyny, Inc. | $26.37 | −14.27% | +2.45% | +14.55% |
| S1RP34.SA | Sarepta Therapeutics, Inc. | 4.82 BRL | +24.55% | −17.18% | −12.20% |
| FLRY3.SA | Fleury S.A. | 18.66 BRL | +9.38% | +25.83% | +37.82% |
| TSHA | Taysha Gene Therapies, Inc. | $6.02 | +10.26% | +14.67% | +102.69% |
| EMBLA.CO | Embla Medical hf. | 30.15 DKK | +5.05% | −5.78% | −6.94% |
| GXE.DE | Lakefront Biotherapeutics NV | 24.68 EUR | +0.82% | −12.36% | −44.50% |
| IMCR | Immunocore Holdings plc | $37.12 | +10.77% | +9.89% | +13.69% |
| ASTH | Astrana Health, Inc. | $38.61 | +1.69% | +53.09% | +23.71% |
| LKFT | Lakefront Biotherapeutics NV | $29.16 | +3.59% | −11.56% | −11.39% |
| SNDA | Sonida Senior Living, Inc. | $39.67 | −7.89% | +24.24% | +51.53% |
| NTLA | Intellia Therapeutics, Inc. | $13.19 | +21.12% | +43.21% | +15.50% |
| DMRA | Damora Therapeutics, Inc. | $30.39 | +3.30% | +39.28% | +804.46% |
| SEPN | Septerna, Inc. | $40.25 | +18.49% | +43.85% | +218.81% |
| NEU.AX | Neuren Pharmaceuticals Limited | 20.59 AUD | +20.20% | +8.88% | +5.54% |
| RXRX | Recursion Pharmaceuticals, Inc. | $3.49 | +14.43% | −16.90% | −28.63% |
| DRW8.DE | Drägerwerk AG & Co. KGaA | 82.40 EUR | +8.42% | +52.87% | +53.42% |
| SGRY | Surgery Partners, Inc. | $14.04 | −9.88% | −7.99% | −38.48% |
| PSNL | Personalis, Inc. | $17.08 | +43.77% | +117.58% | +257.32% |
| LMAT | LeMaitre Vascular, Inc. | $79.61 | −22.18% | −0.22% | −16.20% |
| 4540.T | Tsumura & Co. | 3,828.00 JPY | −5.36% | −5.27% | +10.98% |
| INSP | Inspire Medical Systems, Inc. | $61.80 | +18.91% | −33.02% | −33.04% |
| ATT.ST | Attendo AB (publ) | 117.90 SEK | +7.57% | +49.22% | +80.74% |
| SNDX | Syndax Pharmaceuticals, Inc. | $20.09 | +2.34% | −5.68% | +23.55% |
| FTRE | Fortrea Holdings Inc. | $18.53 | −10.48% | +10.23% | +105.20% |
| ALVO | Alvotech | $4.91 | +58.39% | −1.80% | −38.85% |
| ALVO-SDB.ST | Alvotech | 46.45 SEK | +33.67% | +1.57% | −39.57% |
| ANAB | AnaptysBio, Inc. | $58.00 | +11.30% | +93.55% | +326.47% |
| ANIP | ANI Pharmaceuticals, Inc. | $74.56 | −8.00% | −4.93% | −18.85% |
| MAZE | Maze Therapeutics, Inc. | $29.58 | +6.10% | −25.62% | +113.27% |
| CLARI.PA | Clariane SE | 4.01 EUR | −0.89% | +2.14% | −6.95% |
| SIA.TO | Sienna Senior Living Inc. | 21.63 CAD | −6.89% | +7.73% | +25.96% |
| 7716.T | Nakanishi Inc. | 3,155.00 JPY | +5.94% | +58.15% | +52.27% |
| AVLN | Avalyn Pharma Inc. | $37.04 | +33.29% | +25.60% | +25.60% |
| BCAX | Bicara Therapeutics Inc. | $24.73 | −8.00% | +50.98% | +105.74% |
| 8129.T | Toho Holdings Co., Ltd. | 3,927.00 JPY | −9.06% | −14.11% | −24.33% |
| AGL | agilon health, inc. | $95.74 | −3.43% | +468.19% | +194.58% |
| PYC.AX | PYC Therapeutics Limited | 2.25 AUD | +38.46% | +35.95% | +74.42% |
| 4DX.AX | 4DMedical Limited | 3.70 AUD | +13.34% | −18.61% | +669.79% |
| ARDT | Ardent Health, Inc. | $11.23 | −2.09% | +29.98% | −11.64% |
| XERS | Xeris Biopharma Holdings, Inc. | $8.68 | +5.34% | +18.10% | +8.64% |
| ABSI | Absci Corporation | $9.22 | +29.31% | +155.40% | +261.57% |
| TRAX | First Tracks Biotherapeutics, Inc. | $44.19 | +5.59% | +132.58% | +132.58% |
| AAPG | Ascentage Pharma Group Internat | $16.90 | −7.57% | −35.91% | −59.18% |
| A2RR34.SA | Arrowhead Pharmaceuticals, Inc. | 57.60 BRL | +8.15% | +25.08% | +298.89% |
| HCSG | Healthcare Services Group, Inc. | $22.91 | −3.54% | +32.05% | +47.05% |
| 8086.T | Nipro Corporation | 1,535.50 JPY | −8.00% | +4.31% | +4.28% |
| BONEX.ST | Bonesupport Holding AB (publ) | 224.40 SEK | +1.54% | +26.07% | −28.26% |
| TYRA | Tyra Biosciences, Inc. | $26.22 | −15.09% | −2.13% | +103.57% |
| KMTS | Kestra Medical Technologies, Ltd. | $26.57 | +11.36% | +8.94% | +47.61% |
| LBRX | LB Pharmaceuticals Inc | $48.17 | +37.85% | +135.64% | +178.41% |
| DIA.WA | Diagnostyka S.A. | 167.60 PLN | +0.72% | −3.07% | −17.76% |
| AVBP | ArriVent BioPharma, Inc. | $31.14 | +3.87% | +49.71% | +62.10% |
| CNMD | CONMED Corporation | $50.48 | +14.08% | +24.58% | −6.91% |
| INVA | Innoviva, Inc. | $21.24 | −2.61% | +6.89% | +7.06% |
| OMCL | Omnicell, Inc. | $33.45 | −22.30% | −25.90% | +0.66% |
| 4516.T | Nippon Shinyaku Co., Ltd. | 3,588.00 JPY | +1.07% | −34.41% | +19.48% |
| NVAX | Novavax, Inc. | $9.21 | +24.97% | +29.17% | +21.50% |
| NOLA-B.ST | Nolato AB (publ) | 51.80 SEK | +6.91% | −10.27% | −7.00% |
| 6849.T | Nihon Kohden Corporation | 1,491.00 JPY | −10.13% | −11.05% | −7.26% |
| REPL | Replimune Group, Inc. | $15.88 | +196.82% | +78.43% | +187.16% |
| TNDM | Tandem Diabetes Care, Inc. Common Stock | $21.37 | +20.33% | −0.84% | +74.45% |
| RDC.DE | Redcare Pharmacy NV | 62.05 EUR | −10.46% | −6.06% | −23.82% |
| INNV | InnovAge Holding Corp. | $11.04 | −6.52% | +112.72% | +178.79% |
| AKTS | Aktis Oncology, Inc. | $26.51 | +15.41% | +18.35% | +18.35% |
| AZTA | Azenta, Inc. | $33.57 | +16.04% | +0.54% | +11.16% |
| OMDA | Omada Health, Inc. | $23.96 | +17.28% | +60.81% | +2.74% |
| PAHC | Phibro Animal Health Corporation | $36.09 | −0.77% | −3.02% | +13.01% |
| SDGR | Schrödinger, Inc. | $19.47 | +27.34% | +8.29% | −1.62% |
| ENOV | Enovis Corporation | $25.25 | −14.46% | −4.75% | −18.60% |
| ATEC | Alphatec Holdings, Inc. | $9.42 | +1.07% | −54.62% | −41.78% |
| ORIC | ORIC Pharmaceuticals, Inc. | $13.91 | +16.79% | +70.26% | +35.58% |
| MGTX | MeiraGTx Holdings plc | $14.92 | +26.23% | +91.04% | +100.54% |
| 4483.T | JMDC Inc. | 3,440.00 JPY | +5.52% | −11.43% | −17.21% |
| GDS.PA | Ramsay Générale de Santé SA | 10.95 EUR | −0.45% | +17.24% | +9.50% |
| IMTX | Immatics N.V. | $9.43 | +7.96% | −9.76% | +74.63% |
| JBIO | Jade Biosciences, Inc. | $21.33 | +8.27% | +50.64% | +168.30% |
| DRTS | Alpha Tau Medical Ltd. | $14.96 | +29.52% | +209.73% | +343.92% |
| 3148.T | Create SD Holdings Co., Ltd. | 3,410.00 JPY | −3.26% | +3.54% | +1.90% |
| 9627.T | Ain Holdings Inc. | 6,142.00 JPY | −2.57% | −5.73% | +2.85% |
| VITR.ST | Vitrolife AB (publ) | 95.10 SEK | +9.31% | −27.76% | −30.23% |
| 3360.T | Ship Healthcare Holdings, Inc. | 2,350.00 JPY | −8.38% | −8.58% | +8.25% |
| NUTX | Nutex Health Inc. | $195.92 | +31.46% | +32.21% | +118.22% |
| PNTG | The Pennant Group, Inc. | $38.28 | −8.90% | +37.55% | +56.31% |
| UPR.L | Uniphar plc | 370.00 GBP | −1.33% | +23.75% | +6.94% |
| AORT | Artivion, Inc. | $27.20 | +0.70% | −38.82% | −37.81% |
| AMN | AMN Healthcare Services, Inc. | $34.24 | −1.30% | +126.46% | +70.26% |
| MLTX | MoonLake Immunotherapeutics | $15.62 | −16.52% | +30.71% | −71.82% |
| REG.AX | Regis Healthcare Limited | 6.09 AUD | −4.09% | −11.19% | −20.05% |
| MNKD | MannKind Corporation | $4.09 | +4.60% | −26.96% | −9.51% |
| IART | Integra LifeSciences Holdings Corporation | $16.88 | −14.57% | +40.55% | +13.52% |
| VOR | Vor Biopharma Inc. | $23.67 | +18.35% | +103.35% | −40.82% |
| SPI.L | Spire Healthcare Group plc | 237.00 GBP | +1.28% | +40.25% | +7.25% |
| RYM.AX | RYM FPO NZX [RYM] | 1.74 AUD | −8.42% | −32.30% | −27.80% |
| 4544.T | H.U. Group Holdings, Inc. | 3,634.00 JPY | +1.08% | +8.30% | +2.77% |
| SANA | Sana Biotechnology, Inc. | $4.16 | +26.44% | −0.72% | +23.44% |
| GDRX | GoodRx Holdings, Inc. | $3.65 | +16.99% | +32.73% | −18.89% |
| CERT | Certara, Inc. | $8.22 | +3.92% | −5.95% | −25.07% |
| 2175.T | SMS Co., Ltd. | 2,391.00 JPY | +0.80% | +80.27% | +54.71% |
| ODTX | Odyssey Therapeutics, Inc. | $25.62 | +39.01% | +56.03% | +56.03% |
| GLUE | Monte Rosa Therapeutics, Inc. | $14.38 | −34.75% | −6.07% | +207.92% |
| BIOG-B.ST | BioGaia AB (publ) | 117.10 SEK | +1.39% | +15.05% | +13.96% |
| CRVS | Corvus Pharmaceuticals, Inc. | $14.73 | +10.67% | +101.23% | +167.82% |
| SNZ.AX | Summerset Group Holdings Limited | 7.00 AUD | −0.14% | −32.73% | −26.63% |
| 4553.T | Towa Pharmaceutical Co., Ltd. | 3,915.00 JPY | −7.56% | +9.34% | +34.65% |
| PRCT | PROCEPT BioRobotics Corporation | $21.07 | +16.54% | −31.50% | −48.36% |
| CVSG.L | CVS Group plc | 1,296.00 GBP | +3.27% | +1.73% | +2.05% |
| 4887.T | Sawai Group Holdings Co., Ltd. | 1,607.50 JPY | −6.02% | −31.23% | −12.86% |
| AVNS | Avanos Medical Inc | $24.99 | +0.04% | +123.52% | +110.53% |
| USPH | U.S. Physical Therapy, Inc. | $78.27 | −0.92% | +0.55% | −5.67% |
| KURA | Kura Oncology, Inc. | $13.06 | +40.28% | +26.37% | +66.16% |
| TDOC | Teladoc Health, Inc. | $6.33 | −32.37% | −10.21% | −18.22% |
| SVRA | Savara Inc. | $5.61 | +5.25% | −0.53% | +70.52% |
| LMRI | Lumexa Imaging Holdings, Inc. | $11.96 | +9.02% | −31.85% | −35.42% |
| STAA | STAAR Surgical Company | $22.86 | +0.88% | −3.14% | −16.90% |
| IVA.PA | Inventiva S.A. | 4.09 EUR | +3.94% | +0.99% | −14.63% |
| RHK.DE | RHÖN-KLINIKUM Aktiengesellschaft | 14.70 EUR | +13.08% | +15.81% | +24.49% |
| IVA | Inventiva S.A. | $4.82 | +3.88% | +1.26% | −7.84% |
| 2160.T | GNI Group Ltd. | 2,879.00 JPY | +25.17% | +25.72% | +8.36% |
| TTALO.HE | Terveystalo Oyj | 7.78 EUR | +4.29% | −16.20% | −22.31% |
| T2DH34.SA | Teladoc Health, Inc. | 32.09 BRL | −32.46% | −15.77% | −24.67% |
| SPH.WA | Sopharma AD | 7.76 PLN | +8.08% | −39.14% | −38.71% |
| IRMD | IRADIMED CORPORATION | $87.47 | −7.76% | −8.02% | +19.80% |
| OPK | OPKO Health, Inc. | $1.51 | −8.48% | +18.90% | +6.34% |
| 7476.T | AS ONE Corporation | 2,473.00 JPY | −4.18% | +4.62% | +2.31% |
| PHIL.MI | Philogen S.p.A. | 23.85 EUR | +1.06% | +6.10% | +4.75% |
| AVTX | Avalo Therapeutics, Inc. | $20.55 | +5.28% | +20.74% | +112.95% |
| J2AZ34.SA | Jazz Pharmaceuticals plc | 88.80 BRL | −0.54% | +35.66% | +35.66% |
| 4547.T | Kissei Pharmaceutical Co., Ltd. | 4,095.00 JPY | −5.54% | −9.37% | −1.28% |
| 006280.KS | GC Biopharma Corp. | 127,100.00 KRW | +12.28% | −19.46% | −2.60% |
| SLDB | Solid Biosciences Inc. | $9.72 | +21.96% | +78.35% | +72.95% |
| LXRX | Lexicon Pharmaceuticals, Inc. | $2.31 | −1.28% | +102.63% | +104.42% |
| CSTL | Castle Biosciences, Inc. | $34.08 | +42.65% | −11.57% | +52.96% |
| 069620.KS | Daewoong Pharmaceutical Co., Ltd | 124,000.00 KRW | +1.56% | −25.30% | −9.51% |
| WVE | Wave Life Sciences, Inc. | $5.23 | −11.21% | −67.21% | −48.12% |
| ABUS | Arbutus Biopharma Corporation | $5.19 | +17.69% | +8.81% | +42.19% |
| GUBRA.CO | Gubra A/S | 402.40 DKK | +6.23% | −24.64% | +4.79% |
| GXI.DE | Gerresheimer AG | 25.58 EUR | −9.23% | −7.99% | −39.73% |
| QDEL | QuidelOrtho Corporation | $14.91 | −10.56% | −48.19% | −46.31% |
| MEDCL.PA | MedinCell S.A. | 24.58 EUR | −6.18% | −0.57% | +41.92% |
| PCRX | Pacira BioSciences, Inc. | $25.90 | −3.39% | +5.89% | −0.88% |
| CADL | Candel Therapeutics, Inc. | $13.28 | +37.19% | +144.12% | +124.70% |
| GERN | Geron Corporation | $1.53 | +5.52% | +15.91% | +8.51% |
| 7730.T | Mani, Inc. | 1,607.00 JPY | +5.38% | +10.38% | +29.48% |
| DSGN | Design Therapeutics, Inc. | $15.59 | +31.34% | +71.32% | +194.71% |
| VETO.PA | Vetoquinol SA | 70.60 EUR | −3.29% | −16.35% | −6.37% |
| BVS | Bioventus Inc. | $13.97 | +5.75% | +93.76% | +86.52% |
| EUZ.DE | Eckert & Ziegler SE | 13.18 EUR | −4.56% | −12.19% | −24.60% |
| 4521.T | Kaken Pharmaceutical Co., Ltd. | 3,995.00 JPY | +0.13% | +1.77% | +10.07% |
| OLMA | Olema Pharmaceuticals, Inc. | $10.85 | −6.63% | −57.08% | +89.02% |
| NEU.WA | NEUCA S.A. | 758.00 PLN | +1.34% | −9.22% | +15.02% |
| ANNX | Annexon, Inc. | $4.99 | +0.40% | +6.40% | +136.49% |
| DBVT | DBV Technologies S.A. | $14.52 | +7.56% | −23.78% | +53.00% |
| AMPH | Amphastar Pharmaceuticals, Inc. | $22.02 | +9.28% | −16.78% | −27.78% |
| XVIVO.ST | Xvivo Perfusion AB (publ) | 278.80 SEK | +9.08% | +53.95% | +59.31% |
| CLYM | Climb Bio Inc | $16.08 | +30.84% | +328.80% | +603.72% |
| PHN.MI | Pharmanutra S.p.A. | 81.50 EUR | −1.81% | +53.54% | +70.46% |
| 3046.T | JINS HOLDINGS Inc. | 6,230.00 JPY | −9.58% | +14.30% | −22.48% |
| ACRS | Aclaris Therapeutics, Inc. | $6.19 | +16.14% | +114.93% | +240.11% |
| B2RK34.SA | Bruker Corporation | 30.63 BRL | −0.49% | +63.27% | +63.27% |
| DBV.PA | DBV Technologies S.A. | 2.53 EUR | +5.42% | −22.51% | +60.13% |
| CBLL | CeriBell, Inc. | $23.45 | +31.52% | +10.09% | +102.16% |
| 4587.T | PeptiDream Inc. | 1,107.50 JPY | +16.74% | −31.68% | −27.31% |
| SGP | SpyGlass Pharma, Inc. | $26.64 | +23.22% | +0.91% | +0.91% |
| ANL | Adlai Nortye Ltd. | $15.06 | +18.68% | +991.30% | +791.12% |
| TBPH | Theravance Biopharma, Inc. | $17.03 | +0.83% | −6.17% | +23.41% |
| SYNSAM.ST | Synsam AB (publ) | 59.50 SEK | +5.50% | −7.98% | +5.66% |
| 7780.T | Menicon Co., Ltd. | 1,884.00 JPY | +4.09% | +21.53% | +54.36% |
| TALK | Talkspace, Inc. | $5.25 | +0.77% | +49.57% | +93.73% |
| BBNX | Beta Bionics, Inc. | $19.34 | +22.41% | −33.88% | +1.95% |
| AVR | Anteris Technologies Global Corp. | $8.95 | +9.55% | +81.91% | +144.54% |
| RIGL | Rigel Pharmaceuticals, Inc. | $46.48 | +20.73% | +11.12% | +16.99% |
| INMD | InMode Ltd. | $14.93 | −3.49% | +0.88% | −1.71% |
| MCAP.ST | MedCap AB (publ) | 554.50 SEK | +3.64% | +4.03% | −10.28% |
| SIBN | SI-BONE, Inc. | $19.43 | +8.37% | −1.82% | +17.12% |
| AVR.AX | Anteris Technologies Global Corp. | 12.28 AUD | +3.63% | +64.83% | +106.39% |
| FDMT | 4D Molecular Therapeutics, Inc. | $15.56 | +57.97% | +112.57% | +140.87% |
| COLL | Collegium Pharmaceutical, Inc. | $27.51 | −23.37% | −39.58% | −29.08% |
| 4694.T | BML, Inc. | 3,625.00 JPY | −2.03% | −3.47% | +5.42% |
| DYVOX.ST | Dynavox Group AB (publ) | 76.70 SEK | +4.14% | −21.71% | −39.29% |
| AHG | Akso Health Group | $0.99 | −32.19% | −38.12% | −43.10% |
| OXB.L | Oxford Biomedica plc | 515.00 GBP | −5.68% | −21.37% | −9.81% |
| PHAR | Pharming Group N.V. | $11.95 | −7.08% | −30.28% | −14.47% |
| SLN | Silence Therapeutics plc | $13.53 | +17.14% | +120.00% | +160.19% |
| HSTM | HealthStream, Inc. | $28.76 | −0.31% | +26.59% | +1.86% |
| SFL.MI | Safilo Group S.p.A. | 1.85 EUR | +14.02% | −5.33% | +20.65% |
| AMS.L | Advanced Medical Solutions Group plc | 281.50 GBP | +0.36% | +29.14% | +38.01% |
| GNFT.PA | Genfit S.A. | 14.30 EUR | +5.30% | +172.38% | +310.45% |
| APOTEA.ST | Apotea AB (publ) | 75.30 SEK | +1.41% | −16.05% | −26.38% |
| ESPR | Esperion Therapeutics, Inc. Common Stock | $3.18 | 0.00% | −14.29% | +45.87% |
| NVCT | Nuvectis Pharma, Inc. | $25.00 | +26.14% | +193.77% | +275.94% |
| EIQ.AX | Echo IQ Limited | 1.53 AUD | +21.03% | +498.04% | +609.30% |
| WELL.TO | WELL Health Technologies Corp. | 4.38 CAD | +9.23% | +8.15% | −8.18% |
| ARJO-B.ST | Arjo AB (publ) | 28.38 SEK | +4.11% | −6.88% | −15.25% |
| AURA | Aura Biosciences, Inc. | $7.73 | +9.65% | +45.85% | +20.03% |
| UU8.F | Neurogene Inc. | 33.20 EUR | +21.17% | +29.18% | +165.60% |
| STTK | Shattuck Labs, Inc. | $7.90 | +15.84% | +112.94% | +690.00% |
| SNT.WA | Synektik Spólka Akcyjna | 338.40 PLN | −5.58% | +21.82% | +53.07% |
| NGNE | Neurogene Inc. | $38.41 | +15.62% | +90.53% | +95.02% |
| 001067.KS | JW Pharmaceutical Corporation | 46,100.00 KRW | +5.73% | −21.21% | −23.16% |
| MNPR | Monopar Therapeutics Inc. | $113.72 | +4.24% | +72.28% | +226.69% |
| DRUG | Bright Minds Biosciences Inc. | $76.63 | +6.49% | −8.18% | +76.73% |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | $9.26 | +7.80% | −24.65% | −0.43% |
| D2OC34.SA | Doximity, Inc. | 21.20 BRL | +16.10% | −48.15% | −65.76% |
| 4534.T | Mochida Pharmaceutical Co., Ltd. | 3,290.00 JPY | +1.39% | −6.04% | +7.74% |
| CTMX | CytomX Therapeutics, Inc. | $3.32 | +3.11% | −21.88% | +60.39% |
| OCS | Oculis Holding AG | $12.97 | +17.32% | −35.15% | −25.14% |
| PHR | Phreesia, Inc. | $11.60 | +6.81% | −28.83% | −63.74% |
| SSII | SS Innovations International, Inc. | $3.57 | −9.16% | −36.81% | −50.55% |
| DHT-UN.TO | DRI Healthcare Trust | 17.63 CAD | −0.51% | +10.64% | +27.29% |
| XOMA | XOMA Royalty Corp | $40.17 | 0.00% | +43.52% | +19.27% |
| PHAT | Phathom Pharmaceuticals, Inc. | $8.77 | −24.79% | −44.18% | −29.50% |
| IRWD | Ironwood Pharmaceuticals, Inc. | $4.29 | +12.89% | +0.47% | +240.48% |
| 9267.T | Genky DrugStores Co., Ltd. | 3,660.00 JPY | −11.91% | −25.91% | −20.07% |
| GYRE | Gyre Therapeutics, Inc. | $6.65 | +11.02% | −2.35% | −18.00% |
| ALLO | Allogene Therapeutics, Inc. | $2.04 | +22.89% | +51.11% | +75.86% |
| C2RS34.SA | CRISPR Therapeutics AG | 36.81 BRL | +20.41% | +2.36% | +0.85% |
| AGMB | AgomAb Therapeutics NV | $14.28 | +13.88% | −2.53% | −2.53% |
| TECX | Tectonic Therapeutic, Inc. | $35.97 | +20.70% | +72.02% | +35.43% |
| ZVRA | Zevra Therapeutics, Inc. | $11.74 | +20.66% | +40.77% | +25.43% |
| EVT.DE | Evotec SE | 3.25 EUR | −6.22% | −41.07% | −45.75% |
| 7575.T | Japan Lifeline Co., Ltd. | 1,565.00 JPY | +7.93% | +0.59% | +12.02% |
| PROK | ProKidney Corp. | $1.74 | +12.99% | −21.97% | −30.12% |
| EVO | Evotec SE | $1.95 | −0.51% | −38.68% | −44.13% |
| GMRS | GMR Solutions Inc. | $12.82 | −1.38% | −8.30% | −8.30% |
| GUD.TO | Knight Therapeutics Inc. | 9.76 CAD | −0.81% | +65.14% | +50.39% |
| DHT-U.TO | DRI Healthcare Trust | $12.56 | +0.88% | +6.68% | +27.68% |
| EIKN | Eikon Therapeutics, Inc. | $11.98 | +26.24% | −20.13% | −20.13% |
| CBIO | Crescent Biopharma, Inc. | $18.02 | +9.61% | +62.64% | +26.46% |
| LBIRD.PA | Lumibird SA | 25.80 EUR | −1.53% | +23.06% | +57.43% |
| 2HQ0.DE | Tilray Brands, Inc. | 4.07 EUR | +21.13% | −48.80% | −67.56% |
| CRMD | CorMedix Inc. | $8.39 | +14.15% | −31.00% | −40.66% |
| PRME | Prime Medicine, Inc. | $3.58 | +15.86% | +1.42% | +4.37% |
| ANGO | AngioDynamics, Inc. | $15.69 | +9.41% | +23.74% | +56.74% |
| 4565.T | Nxera Pharma Co., Ltd. | 1,109.00 JPY | +27.47% | +31.40% | +22.68% |
| MDXG | MiMedx Group, Inc. | $4.42 | +1.38% | −31.79% | −38.35% |
| VSTM | Verastem, Inc. | $7.39 | +18.62% | +2.21% | −20.45% |
| TLRY.TO | Tilray Brands, Inc. | 6.46 CAD | +13.73% | −51.61% | +240.00% |
| CTNM | Contineum Therapeutics, Inc. | $17.02 | +20.20% | +49.43% | +70.03% |
| KIDS | OrthoPediatrics Corp. | $24.03 | +21.12% | +36.85% | +11.10% |
| IDX.AX | Integral Diagnostics Limited | 2.30 AUD | +10.05% | −7.10% | −19.60% |
| 185750.KS | Chong Kun Dang Pharmaceutical Corp. | 67,050.00 KRW | +2.21% | −19.02% | −16.94% |
| TLRY | Tilray Brands, Inc. | $4.64 | +15.14% | −52.26% | −66.13% |
| CTEV | Claritev Corporation | $37.57 | +65.73% | +10.86% | −47.71% |
| 6197.T | Solasto Corporation | 1,118.00 JPY | +0.63% | +30.15% | +136.68% |
| VALN | Valneva SE | $6.70 | +32.31% | −25.24% | −23.49% |
| DASA3.SA | Diagnósticos da América S.A. | 2.61 BRL | −1.51% | −41.74% | +93.33% |
| CU6.AX | Clarity Pharmaceuticals Ltd | 2.37 AUD | +13.16% | −36.25% | −25.63% |
| VLA.PA | Valneva SE | 2.89 EUR | +31.25% | −23.68% | −24.48% |
| AUTL | Autolus Therapeutics plc | $2.33 | +60.69% | +24.60% | +48.41% |
| AYJ.DE | Valneva SE | 2.98 EUR | +35.29% | −23.93% | −21.89% |
| ARVN | Arvinas, Inc. | $9.32 | +13.66% | −18.74% | +15.35% |
| ALT | Altimmune, Inc. | $3.15 | +5.35% | −10.26% | −14.17% |
| MPLT | MapLight Therapeutics, Inc. | $12.86 | +4.47% | −23.32% | −29.88% |
| CTKB | Cytek Biosciences, Inc. | $4.57 | +2.47% | −7.11% | +11.74% |
| 3034.T | Qol Holdings Co., Ltd. | 2,497.00 JPY | +12.88% | +21.60% | +24.35% |
| RGNX | REGENXBIO Inc. | $9.38 | −2.29% | −30.88% | +6.35% |
| CRW.L | Craneware plc | 1,272.00 GBP | +2.75% | −33.40% | −40.83% |
| EQS.PA | Equasens Société anonyme | 34.05 EUR | −1.02% | −24.08% | −25.98% |
| WEAV | Weave Communications, Inc. | $7.31 | +6.10% | +1.95% | −5.68% |
| EOLS | Evolus, Inc. | $8.78 | +41.16% | +30.65% | +15.83% |
| ARTV | Artiva Biotherapeutics, Inc. | $11.77 | +11.78% | +178.25% | +259.94% |
| BWAY | BrainsWay Ltd. | $14.30 | −7.68% | +48.26% | +87.42% |
| 4559.T | Zeria Pharmaceutical Co., Ltd. | 2,062.00 JPY | −5.72% | −0.79% | +3.91% |
| ZURA | Zura Bio Limited | $5.99 | +8.12% | +7.93% | +177.31% |
| DCTH | Delcath Systems, Inc. | $16.40 | +41.99% | +64.82% | +49.91% |
| SPRY | ARS Pharmaceuticals, Inc. | $6.03 | +6.35% | −47.52% | −55.13% |
| RAY-B.ST | RaySearch Laboratories AB (publ) | 181.70 SEK | +3.06% | −15.47% | −29.98% |
| OVID | Ovid Therapeutics Inc. | $2.88 | +22.03% | +63.64% | +128.57% |
| EVH | Evolent Health, Inc. | $4.92 | +31.55% | +26.48% | −48.86% |
| ENTX | Entera Bio Ltd. | $3.19 | −2.15% | +80.23% | +62.76% |
| CERS | Cerus Corporation | $2.74 | −6.16% | +39.09% | +109.16% |
| 005257.KS | GC Corp. | 16,630.00 KRW | +20.51% | −35.95% | −40.16% |
| 003850.KS | Boryung Corporation | 8,940.00 KRW | +18.10% | −4.39% | +9.00% |
| KYTX | Kyverna Therapeutics, Inc. | $8.61 | +14.95% | −1.82% | +133.33% |
| CABA | Cabaletta Bio, Inc. | $3.25 | +19.05% | +47.06% | +116.67% |
| FLGT | Fulgent Genetics, Inc. | $19.81 | +0.92% | −22.59% | −8.46% |
| SRTA | Strata Critical Medical, Inc. | $6.12 | +20.24% | +24.14% | +33.62% |
| AYA.AX | Artrya Limited | 5.03 AUD | +5.45% | −0.79% | +157.95% |
| TCMD | Tactile Systems Technology, Inc. | $23.51 | −15.25% | −14.20% | +78.78% |
| 2664.T | Cawachi Limited | 3,760.00 JPY | +8.20% | +28.43% | +38.25% |
| 137310.KS | SD Biosensor, Inc. | 6,140.00 KRW | +1.66% | −30.67% | −38.35% |
| 003090.KS | Daewoong Co., Ltd. | 17,280.00 KRW | +8.27% | −19.25% | −27.35% |
| BOI.PA | Boiron SA | 25.80 EUR | −5.84% | −14.29% | +21.99% |
| CCCC | C4 Therapeutics, Inc. | $4.24 | +19.44% | +119.69% | +64.34% |
| 019175.KS | Shinpoong Pharmaceutical Co.,Ltd | 13,370.00 KRW | +23.80% | −43.35% | −40.58% |
| 7979.T | Shofu Inc. | 2,321.00 JPY | +6.76% | +30.43% | +21.34% |
| 4480.T | Medley, Inc. | 2,713.00 JPY | +30.12% | +15.94% | +9.22% |
| TOI | Starling Oncology Inc | $6.20 | +25.25% | +68.94% | +79.19% |
| DNA | Ginkgo Bioworks Holdings, Inc. | $7.23 | −6.10% | −16.90% | −41.46% |
| NPCE | NeuroPace, Inc. | $14.68 | −4.11% | −3.23% | +65.32% |
| 3151.T | Vital KSK Holdings, Inc. | 1,670.00 JPY | −2.51% | +21.29% | +40.44% |
| EVMN | Evommune, Inc. | $14.11 | +25.42% | −18.49% | −30.25% |
| CLPT | ClearPoint Neuro, Inc. | $16.37 | +12.66% | +16.68% | +53.85% |
| IMR.AX | Imricor Medical Systems, Inc. | 1.95 AUD | +0.78% | +18.96% | +40.43% |
| J8J.F | TransThera Sciences (Nanjing), Inc. | 1.04 EUR | +0.97% | −90.91% | −90.91% |
| 4592.T | SanBio Company Limited | 997.00 JPY | +10.78% | −39.10% | −57.08% |
| ALVIO.PA | Valerio Therapeutics Société anonyme | 0.81 EUR | +8.00% | +386.49% | +1198.08% |
| CGC | Canopy Growth Corporation | $1.04 | +15.77% | −13.03% | −31.46% |
| EPRX | Eupraxia Pharmaceuticals Inc. | $7.43 | +21.80% | −1.85% | +40.72% |
| WEED.TO | Canopy Growth Corporation | 1.43 CAD | +13.49% | −12.80% | −31.25% |
| EDIT | Editas Medicine, Inc. | $3.18 | +21.37% | +55.12% | +19.10% |
| EPRX.TO | Eupraxia Pharmaceuticals Inc. | 10.28 CAD | +20.23% | −1.72% | +43.78% |
| NRC | NRC Health | $22.00 | −1.52% | +23.14% | +45.92% |
| 4549.T | Eiken Chemical Co., Ltd. | 2,296.00 JPY | −8.71% | −3.54% | −5.16% |
| RLMD | Relmada Therapeutics, Inc. | $4.55 | −13.00% | +4.12% | +579.10% |
| RZLT | Rezolute, Inc. | $5.04 | +2.44% | +132.79% | −30.00% |
| PNV.AX | PolyNovo Limited | 1.03 AUD | +17.05% | −17.60% | −23.99% |
| PACB | Pacific Biosciences of California, Inc. | $1.56 | +12.23% | −15.22% | +17.29% |
| KMDA | Kamada Ltd. Ordinary Shares | $8.38 | +18.70% | +22.82% | +21.09% |
| 317450.KS | MYUNGIN PHARM | 45,750.00 KRW | +14.09% | −25.73% | −55.96% |
| CAPR | Capricor Therapeutics, Inc. | $9.36 | +42.47% | −66.94% | +49.76% |
| AGY.L | Allergy Therapeutics plc | 5.60 GBP | −5.08% | −52.94% | −30.00% |
| PGMN3.SA | Empreendimentos Pague Menos S.A. | 3.45 BRL | +8.15% | −44.80% | −1.57% |
| QTTB | Q32 Bio Inc. | $16.18 | +2.99% | +370.35% | +840.70% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.